James DArecca

CIK: 0001583903

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (45.5%)

Compensation grants

Other (G, F, J, C, D, …)6 (54.5%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

PBH

Prestige Consumer Healthcare Inc.

Director

HAE

HAEMONETICS CORP

Officer

Discretionary Trading P&L

Holdings

Transaction History (11 total)

PBH
Prestige Consumer Healthcare Inc.
Aug 4, 2026
Award(A)
Direct
3K shares-
HAE
HAEMONETICS CORP
May 15, 2026
Award(A)
Direct
29.3K shares-
HAE
HAEMONETICS CORP
May 15, 2026
Tax Payment(F)
Direct
2.5K shares at avg. $56.29$141K
HAE
HAEMONETICS CORP
May 1, 2026
Tax Payment(F)
Direct
655 shares at avg. $59.26$39K
PBH
Prestige Consumer Healthcare Inc.
Aug 5, 2025
Award(A)
Direct
2.1K shares-
HAE
HAEMONETICS CORP
May 30, 2025
Tax Payment(F)
Direct
5.9K shares at avg. $69.38$407K
HAE
HAEMONETICS CORP
May 30, 2025
Award(A)
Direct
12.2K shares-
HAE
HAEMONETICS CORP
May 16, 2025
Award(A)
Direct
7.1K shares-
HAE
HAEMONETICS CORP
May 16, 2025
Tax Payment(F)
Direct
1.2K shares at avg. $70.31$88K
HAE
HAEMONETICS CORP
May 15, 2025
Tax Payment(F)
Direct
622 shares at avg. $69.38$43K
HAE
HAEMONETICS CORP
May 2, 2025
Tax Payment(F)
Direct
654 shares at avg. $63.85$42K

		Type	Shares	Price		Ownership
Aug 4, 2026	PBH Prestige Consumer Healthcare Inc.	Award(A)	2,981	-	$0	Direct
May 15, 2026	HAE HAEMONETICS CORP	Award(A)	29,312	-	$0	Direct
May 15, 2026	HAE HAEMONETICS CORP	Tax Payment(F)	2,505	$56.29	$141,006	Direct
May 1, 2026	HAE HAEMONETICS CORP	Tax Payment(F)	655	$59.26	$38,815	Direct
Aug 5, 2025	PBH Prestige Consumer Healthcare Inc.	Award(A)	2,094	-	-	Direct
May 30, 2025	HAE HAEMONETICS CORP	Tax Payment(F)	5,864	$69.38	$406,844	Direct
May 30, 2025	HAE HAEMONETICS CORP	Award(A)	12,221	-	-	Direct
May 16, 2025	HAE HAEMONETICS CORP	Award(A)	7,111	-	-	Direct
May 16, 2025	HAE HAEMONETICS CORP	Tax Payment(F)	1,246	$70.31	$87,606	Direct
May 15, 2025	HAE HAEMONETICS CORP	Tax Payment(F)	622	$69.38	$43,154	Direct
May 2, 2025	HAE HAEMONETICS CORP	Tax Payment(F)	654	$63.85	$41,758	Direct

1-11 of 11 transactions

About DArecca James

DArecca James (SEC CIK 0001583903) files insider reports with the SEC as Director of Prestige Consumer Healthcare Inc. (PBH) and EVP, Chief Financial Officer of HAEMONETICS CORP (HAE).

Signal8 holds 8 ownership filings by DArecca James, all Form 4s, filed between May 5, 2025 and Aug 5, 2026. Those filings report 11 transactions, from May 2, 2025 to Aug 4, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on DArecca James's filings is in TARRYTOWN, NY.

Recent filings by DArecca James

Aug 4, 2026: Grant or award of PBH shares (Form 4, code A).
May 15, 2026: Grant or award of HAE shares (Form 4, code A).
May 15, 2026: Tax withholding of HAE shares (Form 4, code F).
May 1, 2026: Tax withholding of HAE shares (Form 4, code F).
Aug 5, 2025: Grant or award of PBH shares (Form 4, code A).

Other insiders filing for Prestige Consumer Healthcare Inc. (PBH)

ZIER DAWN M., Director
Kelly John F., Director
Clark Celeste A., Director
BYOM JOHN E, Director
Sacco Christine, CFO & COO
Zerillo Jeffrey, Senior VP Operations

How to read Form 4 transaction codes